1
|
Oldak L, Zielinska Z, Socha K, Bogdan S, Gorodkiewicz E. Phospho-Tau 181 quantification method for Alzheimer's disease based on an array 2D biosensor combined with surface plasmon resonance imaging. Talanta 2024; 271:125736. [PMID: 38316077 DOI: 10.1016/j.talanta.2024.125736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2023] [Revised: 01/09/2024] [Accepted: 01/29/2024] [Indexed: 02/07/2024]
Abstract
Alzheimer's disease is among the neurodegenerative diseases for which there is a lack of rapid, effective, and non-invasive diagnostic methods. The development of a phospho-Tau 181 assay biosensor is therefore a response to the need for methods to diagnose AD. The present work was aimed at developing a fast, selective, and repeatable method for the quantitative determination of phospho-Tau 181, which could be used even during routine blood tests. Our method is a form of what is called liquid biopsy. The developed method underwent validation, as a result of which its analytical parameters were determined. An LOQ of 3.35 pg mL-1 was obtained, confirming the possibility of trace analysis of phospho-Tau 181 in human plasma. Relative percentage error values below 15 % and CVs in the range 1.47-7.09 % attest to the high accuracy and precision of the presented method. Also, the sample matrix was not found to significantly affect the results obtained for phospho-Tau 181 concentrations. The new SPRi biosensor provides reproducible measurements of the analyte under study (CV = 3.18-4.26 %). Although the method requires absolute adherence to the recommendations of the analytical procedure protocol, it achieves high selectivity and provides 90 % certainty of the correctness of the diagnosis based on measurements of phospho-Tau 181 concentration.
Collapse
Affiliation(s)
- Lukasz Oldak
- Faculty of Chemistry, Bioanalysis Laboratory, University of Bialystok, Ciolkowskiego 1K, 15-245, Bialystok, Poland.
| | - Zuzanna Zielinska
- Doctoral School of Exact and Natural Science, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245, Bialystok, Poland.
| | - Katarzyna Socha
- Department of Bromatology, Medical University of Bialystok, Mickiewicza 2D, 15-222, Bialystok, Poland.
| | - Sylwia Bogdan
- Faculty of Chemistry, Bioanalysis Laboratory, University of Bialystok, Ciolkowskiego 1K, 15-245, Bialystok, Poland.
| | - Ewa Gorodkiewicz
- Faculty of Chemistry, Bioanalysis Laboratory, University of Bialystok, Ciolkowskiego 1K, 15-245, Bialystok, Poland.
| |
Collapse
|
2
|
Tufail S, Sherwani MA, Shamim Z, Abdullah, Goh KW, Alomary MN, Ansari MA, Almosa AA, Ming LC, Abdullah ADI, Khan FB, Menhali AA, Mirza S, Ayoub MA. 2D nanostructures: Potential in diagnosis and treatment of Alzheimer's disease. Biomed Pharmacother 2024; 170:116070. [PMID: 38163396 DOI: 10.1016/j.biopha.2023.116070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2023] [Revised: 12/06/2023] [Accepted: 12/21/2023] [Indexed: 01/03/2024] Open
Abstract
Two-dimensional (2D) nanomaterials have garnered enormous attention seemingly due to their unusual architecture and properties. Graphene and graphene oxide based 2D nanomaterials remained the most sought after for several years but the quest to design superior 2D nanomaterials which can find wider application gave rise to development of non-graphene 2D materials as well. Consequently, in addition to graphene based 2D nanomaterials, 2D nanostructures designed using macromolecules (such as DNAs, proteins, peptides and peptoids), transition metal dichalcogenides, transition-metal carbides and/or nitrides (MXene), black phosphorous, chitosan, hexagonal boron nitrides, and graphitic carbon nitride, and covalent organic frameworks have been developed. Interestingly, these 2D nanomaterials have found applications in diagnosis and treatment of various diseases including Alzheimer's disease (AD). Although AD is one of the most debilitating neurodegenerative conditions across the globe; unfortunately, there remains a paucity of effective diagnostic and/or therapeutic intervention for it till date. In this scenario, nanomaterial-based biosensors, or therapeutics especially 2D nanostructures are emerging to be promising in this regard. This review summarizes the diagnostic and therapeutic platforms developed for AD using 2D nanostructures. Collectively, it is worth mentioning that these 2D nanomaterials would seemingly provide an alternative and intriguing platform for biomedical interventions.
Collapse
Affiliation(s)
- Saba Tufail
- Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
| | | | - Zahid Shamim
- Department of Electrical Engineering, Faculty of Engineering and Technology, Aligarh Muslim University, Aligarh, India
| | - Abdullah
- Department of Pharmacy, University of Malakand, Khyber Pakhtunkhwa, Pakistan
| | - Khang Wen Goh
- Faculty Data Science and Information Technology, INTI International University, Nilai, Malaysia
| | - Mohammad N Alomary
- Advanced Diagnostic and Therapeutic Institute, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia
| | - Mohammad Azam Ansari
- Department of Epidemic Disease Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
| | - Abdulaziz Abdullah Almosa
- Wellness and Preventive Medicine Institute, King AbdulAziz City of Science and Technology, Riyadh, Saudi Arabia.
| | - Long Chiau Ming
- Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Sunway City, Malaysia.
| | - Amar Daud Iskandar Abdullah
- Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Sunway City, Malaysia.
| | - Farheen Badrealam Khan
- Department of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates; Department of Biological Sciences, College of Medicine and Health Sciences, Khalifa University, PO Box 127788, Abu Dhabi, United Arab Emirates.
| | - Asma Al Menhali
- Department of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
| | - Sameer Mirza
- Department of Chemistry, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
| | - Mohammed Akli Ayoub
- Department of Biological Sciences, College of Medicine and Health Sciences, Khalifa University, PO Box 127788, Abu Dhabi, United Arab Emirates.
| |
Collapse
|
3
|
Sadeghzadeh J, Shahabi P, Farhoudi M, Ebrahimi-Kalan A, Mobed A, Shahpasand K. Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases. Adv Pharm Bull 2023; 13:502-511. [PMID: 37646056 PMCID: PMC10460811 DOI: 10.34172/apb.2023.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2022] [Revised: 10/01/2022] [Accepted: 11/02/2022] [Indexed: 09/01/2023] Open
Abstract
Tau protein plays a crucial role in diagnosing neurodegenerative diseases. However, performing an assay to detect tau protein on a nanoscale is a great challenge for early diagnosis of diseases. Enzyme-linked immunosorbent assay (ELISA), western-blotting, and molecular-based methods, e.g., PCR and real-time PCR, are the most widely used methods for detecting tau protein. These methods are subject to certain limitations: the need for advanced equipment, low sensitivity, and specificity, to name a few. With the above said, it is necessary to discover advanced and novel methods for monitoring tau protein. Counted among remarkable approaches adopted by researchers, biosensors can largely eliminate the difficulties and limitations associated with conventional methods. The main objective of the present study is to review the latest biosensors developed to detect the tau protein. Furthermore, the problems and limitations of conventional diagnosis methods were discussed in detail.
Collapse
Affiliation(s)
- Jafar Sadeghzadeh
- Department of Neurosciences and Cognition, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences,Tabriz, Iran
| | - Parviz Shahabi
- Department of Physiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Mehdi Farhoudi
- Department of Neurosciences and Cognition, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences,Tabriz, Iran
| | - Abbas Ebrahimi-Kalan
- Neuroscience Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Ahmad Mobed
- Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Kourosh Shahpasand
- Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology (RI-SCBT), Tehran, Iran
| |
Collapse
|
4
|
Liu X, Liu Y, Liu Q. Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer's Disease. BIOSENSORS 2023; 13:bios13050515. [PMID: 37232876 DOI: 10.3390/bios13050515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 04/22/2023] [Accepted: 04/28/2023] [Indexed: 05/27/2023]
Abstract
Alzheimer's disease (AD) is an irreversible neurodegenerative disease with clinical symptoms of memory loss and cognitive impairment. Currently, no effective drug or therapeutic method is available for curing this disease. The major strategy used is to identify and block AD at its initial stage. Thus, early diagnosis is very important for intervention of the disease and assessment of drug efficacy. The gold standards of clinical diagnosis include the measurement of AD biomarkers in cerebrospinal fluid and positron emission tomography imaging of the brain for amyloid-β (Aβ) deposits. However, these methods are difficult to apply to the general screening of a large aging population because of their high cost, radioactivity and inaccessibility. Comparatively, blood sample detection is less invasive and more accessible for the diagnosis of AD. Hence, a variety of assays based on fluorescence analysis, surface-enhanced Raman scattering, electrochemistry, etc., were developed for the detection of AD biomarkers in blood. These methods play significant roles in recognizing asymptomatic AD and predicting the course of the disease. In a clinical setting, the combination of blood biomarker detection with brain imaging may enhance the accuracy of early diagnosis. Fluorescence-sensing techniques can be used not only to detect the levels of biomarkers in blood but also to image biomarkers in the brain in real time due to their low toxicity, high sensitivity and good biocompatibility. In this review, we summarize the newly developed fluorescent sensing platforms and their application in detecting and imaging biomarkers of AD, such as Aβ and tau in the last five years, and discuss their prospects for clinical applications.
Collapse
Affiliation(s)
- Xingyun Liu
- Department of Chemistry, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China
| | - Yibiao Liu
- Longgang District Central Hospital of Shenzhen, Shenzhen 518116, China
- Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Fundamental Research Institutions, Shenzhen 518055, China
| | - Qiong Liu
- Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Fundamental Research Institutions, Shenzhen 518055, China
- Shenzhen Key Laboratory of Marine Biotechnology and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518055, China
| |
Collapse
|
5
|
Rouhi N, Akhgari A, Orouji N, Nezami A, Rahimzadegan M, Kamali H. Recent progress in the graphene-based biosensing approaches for the detection of Alzheimer's biomarkers. J Pharm Biomed Anal 2023; 222:115084. [DOI: 10.1016/j.jpba.2022.115084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2022] [Revised: 09/15/2022] [Accepted: 09/26/2022] [Indexed: 12/01/2022]
|
6
|
Detection and modulation of neurodegenerative processes using graphene-based nanomaterials: Nanoarchitectonics and applications. Adv Colloid Interface Sci 2023; 311:102824. [PMID: 36549182 DOI: 10.1016/j.cis.2022.102824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Revised: 12/02/2022] [Accepted: 12/08/2022] [Indexed: 12/14/2022]
Abstract
Neurodegenerative disorders (NDDs) are caused by progressive loss of functional neurons following the aggregation and fibrillation of proteins in the central nervous system. The incidence rate continues to rise alarmingly worldwide, particularly in aged population, and the success of treatment remains limited to symptomatic relief. Graphene nanomaterials (GNs) have attracted immense interest on the account of their unique physicochemical and optoelectronic properties. The research over the past two decades has recognized their ability to interact with aggregation-prone neuronal proteins, regulate autophagy and modulate the electrophysiology of neuronal cells. Graphene can prevent the formation of higher order protein aggregates and facilitate the clearance of such deposits. In this review, after highlighting the role of protein fibrillation in neurodegeneration, we have discussed how GN-protein interactions can be exploited for preventing neurodegeneration. A comprehensive understanding of such interactions would contribute to the exploration of novel modalities for controlling neurodegenerative processes.
Collapse
|
7
|
Lu X, Hou X, Tang H, Yi X, Wang J. A High-Quality CdSe/CdS/ZnS Quantum-Dot-Based FRET Aptasensor for the Simultaneous Detection of Two Different Alzheimer's Disease Core Biomarkers. NANOMATERIALS (BASEL, SWITZERLAND) 2022; 12:nano12224031. [PMID: 36432316 PMCID: PMC9697525 DOI: 10.3390/nano12224031] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Revised: 11/06/2022] [Accepted: 11/12/2022] [Indexed: 05/31/2023]
Abstract
The simultaneous detection of two different biomarkers for the point-of-care diagnosis of major diseases, such as Alzheimer’s disease (AD), is greatly challenging. Due to the outstanding photoluminescence (PL) properties of quantum dots (QDs), a high-quality CdSe/CdS/ZnS QD-based fluorescence resonance energy transfer (FRET) aptasensor for simultaneously monitoring the amyloid-β oligomers (AβO) and tau protein was proposed. By engineering the interior inorganic structure and inorganic−organic interface, water-soluble dual-color CdSe/CdS/ZnS QDs with a near-unity PL quantum yield (>90%) and mono-exponential PL decay dynamics were generated. The π−π stacking and hydrogen bond interaction between the aptamer-functionalized dual-color QDs and gold nanorods@polydopamine (Au NRs@PDA) nanoparticles resulted in significant fluorescence quenching of the QDs through FRET. Upon the incorporation of the AβO and tau protein, the fluorescence recovery of the QDs-DNA/Au NRs@PDA assembly was attained, providing the possibility of simultaneously assaying the two types of AD core biomarkers. The lower detection limits of 50 pM for AβO and 20 pM for the tau protein could be ascribed to the distinguishable and robust fluorescence of QDs and broad spectral absorption of Au NRs@PDA. The sensing strategy serves as a viable platform for the simultaneously monitoring of the core biomarkers for AD and other major diseases.
Collapse
Affiliation(s)
- Xingchang Lu
- Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Xiaoqi Hou
- School of Chemistry and Material Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, 1 Sub-lane Xiangshan, Hangzhou 310024, China
- Key Laboratory of Intelligent Sensing Materials and Chip Integration Technology of Zhejiang Province, Hangzhou Innovation Institute, Beihang University, Hangzhou 310052, China
| | - Hailin Tang
- SunYat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
| | - Xinyao Yi
- Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| | - Jianxiu Wang
- Hunan Provincial Key Laboratory of Micro & Nano Materials Interface Science, College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, China
| |
Collapse
|
8
|
Chen KL, Tsai PH, Lin CW, Chen JM, Lin YJ, Kumar P, Jeng CC, Wu CH, Wang LM, Tsao HM. Sensitivity enhancement of magneto-optical Faraday effect immunoassay method based on biofunctionalized γ-Fe 2O 3@Au core-shell magneto-plasmonic nanoparticles for the blood detection of Alzheimer's disease. NANOMEDICINE : NANOTECHNOLOGY, BIOLOGY, AND MEDICINE 2022; 46:102601. [PMID: 36089233 DOI: 10.1016/j.nano.2022.102601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Revised: 08/16/2022] [Accepted: 08/29/2022] [Indexed: 06/15/2023]
Abstract
In this work, we conducted a proof-of-concept experiment based on biofunctionalized magneto-plasmonic nanoparticles (MPNs) and magneto-optical Faraday effect for in vitro Alzheimer's disease (AD) assay. The biofunctionalized γ-Fe2O3@Au MPNs of which the surfaces are modified with the antibody of Tau protein (anti-τ). As anti-τ reacts with Tau protein, biofunctionalized MPNs aggregate to form magnetic clusters which will hence induce the change of the reagent's Faraday rotation angle. The result showed that the γ-Fe2O3@Au core-shell MPNs can enhance the Faraday rotation with respect to the raw γ-Fe2O3 nanoparticles. Because of their magneto-optical enhancement effect, biofunctionalized γ-Fe2O3@Au MPNs effectively improve the detection sensitivity. The detection limit of Tau protein as low as 9 pg/mL (9 ppt) was achieved. Furthermore, the measurements of the clinical samples from AD patients agreed with the CDR evaluated by the neurologist. The results suggest that our method has the potential for disease assay applications.
Collapse
Affiliation(s)
- Kuen-Lin Chen
- Institute of Nanoscience, National Chung Hsing University, Taichung, Taiwan; Department of Physics, National Chung Hsing University, Taichung, Taiwan.
| | - Ping-Huang Tsai
- Department of Neurology, National Yang Ming Chiao Tung University Hospital, Yilan, Taiwan.; Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, Taiwan
| | - Chin-Wei Lin
- Graduate Institute of Applied Physics, National Taiwan University, Taipei, Taiwan
| | - Jian-Ming Chen
- Institute of Nanoscience, National Chung Hsing University, Taichung, Taiwan
| | - You-Jun Lin
- Institute of Nanoscience, National Chung Hsing University, Taichung, Taiwan
| | - Pradeep Kumar
- Department of Physics, National Chung Hsing University, Taichung, Taiwan
| | - Chien-Chung Jeng
- Institute of Nanoscience, National Chung Hsing University, Taichung, Taiwan; Department of Physics, National Chung Hsing University, Taichung, Taiwan
| | - Chiu-Hsien Wu
- Institute of Nanoscience, National Chung Hsing University, Taichung, Taiwan; Department of Physics, National Chung Hsing University, Taichung, Taiwan
| | - Li-Min Wang
- Graduate Institute of Applied Physics, National Taiwan University, Taipei, Taiwan
| | - Hsuan-Ming Tsao
- Division of Cardiology, National Yang Ming Chiao Tung University Hospital, Yilan, Taiwan
| |
Collapse
|
9
|
Chattopadhyay S, Choudhary M, Singh H. Carbon dots and graphene oxide based FRET immunosensor for sensitive detection of Helicobacter pylori. Anal Biochem 2022; 654:114801. [DOI: 10.1016/j.ab.2022.114801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Revised: 06/15/2022] [Accepted: 06/28/2022] [Indexed: 02/06/2023]
|
10
|
Graphene oxide and fluorescent aptamer based novel biosensor for detection of 25-hydroxyvitamin D 3. Sci Rep 2021; 11:23456. [PMID: 34873222 PMCID: PMC8649066 DOI: 10.1038/s41598-021-02837-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Accepted: 11/08/2021] [Indexed: 02/07/2023] Open
Abstract
For maintaining the healthy metabolic status, vitamin D is a beneficial metabolite stored majorly in its pre-activated form, 25-hydroxyvitamin D3 (25(OH)D3). Due to its important role in bone strengthening, the study was planned to quantify 25(OH)D3 levels in our blood. Quantification techniques for 25(OH)D3 are costly thus requiring a need for a low cost, and sensitive detection methods. In this work, an economic, and sensitive sensor for the detection of 25(OH)D3 was developed using aptamer and graphene oxide (GO). Aptamer is an oligonucleotide, sensitive towards its target, whereas, GO with 2D nanosheets provides excellent quenching surface. Aptamer labeled with fluorescein (5’, 6-FAM) is adsorbed by π–π interaction on the GO sheets leading to quenching of the fluorescence due to Förster resonance energy transfer (FRET). However, in the presence of 25(OH)D3, a major portion of aptamer fluorescence remains unaltered, due to its association with 25(OH)D3. However, in the absence, aptamer fluorescence gets fully quenched. Fluorescence intensity quenching was monitored using fluorescence spectrophotometer and agarose gel based system. The limit of detection of 25(OH)D3 by this method was found to be 0.15 µg/mL whereas when GO-COOH was used, limit of detection was improved to 0.075 µg/mL. Therefore, this method could come up as a new sensing method in the field of vitamin D detection.
Collapse
|
11
|
Yin M, Xu D, Yu J, Huang S, Gopinath SCB, Kang P. Impedance spectroscopy for identifying tau protein to monitor anesthesia-based issues. Biotechnol Appl Biochem 2021; 69:1805-1811. [PMID: 34453342 DOI: 10.1002/bab.2246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Accepted: 08/23/2021] [Indexed: 11/10/2022]
Abstract
Anesthesia-related drugs cause various side effects and health-related illnesses after surgery. In particular, neurogenerative disorder is a common problem of anesthesia-related drugs. A patient gets anesthesia as a requirement of the preoperative evaluation to diagnose the medical illness, which is caused by anesthetic drug treatment. Different blood-based biomarkers help in identifying the changes appearing in patients after anesthesia treatment. Among them, tau protein is a sensitive biomarker of neurodegenerative diseases, and the fluctuations in tau proteins are highly associated with various diseases. Furthermore, researchers have found unstable levels of tau protein after the anesthesia process. The current research has focused on quantifying tau protein via impedance spectroscopy to identify the problems caused by anesthesia-related drugs. An impedance spectroscopy electrode was modified into a multiwalled carbon nanotube, and an amine-ended aptamer was then attached. This electrode surface was used to quantify the tau protein level and reached the detection limit of 1 fM. The determination coefficient was found to be y = 369.93x + 1144.9, with R2 = 0.9846 in the linear range of 1 fM-1 nM. Furthermore, tau protein spiked human serum was clearly identified on the immobilized aptamer surface, indicating the specific detection.
Collapse
Affiliation(s)
- Miaomiao Yin
- Department of Anesthesiology, Lianyungang Hospital Affiliated to Xuzhou Medical University, Lianyungang, Jiangsu, China
| | - Defang Xu
- Department of Anesthesiology, Tianjin Fourth Center Hospital, Tianjin, China
| | - Jinyong Yu
- Department of Anesthesiology, Zhucheng Maternal and Child Health Hospital, Weifang, Shandong, China
| | - Saisai Huang
- Department of Anesthesiology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
| | - Subash C B Gopinath
- Institute of Nano Electronic Engineering, Universiti Malaysia Perlis (UniMAP), Kangar, Perlis, 01000, Malaysia.,Faculty of Chemical Engineering Technology, Universiti Malaysia Perlis (UniMAP), Arau, Perlis, 02600, Malaysia
| | - Peipei Kang
- Department of Anesthesiology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu, China
| |
Collapse
|
12
|
Novel Electrochemical Molecularly Imprinted Polymer-Based Biosensor for Tau Protein Detection. CHEMOSENSORS 2021. [DOI: 10.3390/chemosensors9090238] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
A novel electrochemical biosensor based on a molecularly imprinted polymer (MIP) was developed for the impedimetric determination of Tau protein, a biomarker of Alzheimer’s disease (AD). Indeed, a recent correlation between AD symptoms and the presence of Tau proteins in their aggregated form made hyperphosphorylated Tau protein (Tangles) a promising biomarker for Alzheimer’s diagnosis. The MIP was directly assembled on a screen-printed carbon electrode (C-SPE) and prepared by electropolymerization of 3-aminophenol (AMP) in the presence of the protein template (p-Tau-441) using cyclic voltammetry. The p-Tau-441 protein bound to the polymeric backbone was digested by the action of the proteolytic activity of proteinase K in urea and then washed away to create vacant sites. The performances of the corresponding imprinted and non-imprinted electrodes were evaluated by electrochemical impedance spectroscopy. The detection limit of the MIP-based sensors was 0.02 pM in PBS buffer pH 5.6. Good selectivity and good results in serum samples were obtained with the developed platform. The biosensor described in this work is a potential tool for screening Tau protein on-site and an attractive complement to clinically established methodologies methods as it is easy to fabricate, has a short response time and is inexpensive.
Collapse
|
13
|
Murti BT, Putri AD, Huang YJ, Wei SM, Peng CW, Yang PK. Clinically oriented Alzheimer's biosensors: expanding the horizons towards point-of-care diagnostics and beyond. RSC Adv 2021; 11:20403-20422. [PMID: 35479927 PMCID: PMC9033966 DOI: 10.1039/d1ra01553b] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Accepted: 05/28/2021] [Indexed: 12/30/2022] Open
Abstract
The development of minimally invasive and easy-to-use sensor devices is of current interest for ultrasensitive detection and signal recognition of Alzheimer's disease (AD) biomarkers. Over the years, tremendous effort has been made on diagnostic platforms specifically targeting neurological markers for AD in order to replace the conventional, laborious, and invasive sampling-based approaches. However, the sophistication of analytical outcomes, marker inaccessibility, and material validity strongly limit the current strategies towards effectively predicting AD. Recently, with the promising progress in biosensor technology, the realization of a clinically applicable sensing platform has become a potential option to enable early diagnosis of AD and other neurodegenerative diseases. In this review, various types of biosensors, which include electrochemical, fluorescent, plasmonic, photoelectrochemical, and field-effect transistor (FET)-based sensor configurations, with better clinical applicability and analytical performance towards AD are highlighted. Moreover, the feasibility of these sensors to achieve point-of-care (POC) diagnosis is also discussed. Furthermore, by grafting nanoscale materials into biosensor architecture, the remarkable enhancement in durability, functionality, and analytical outcome of sensor devices is presented. Finally, future perspectives on further translational and commercialization pathways of clinically driven biosensor devices for AD are discussed and summarized.
Collapse
Affiliation(s)
- Bayu Tri Murti
- Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- Semarang College of Pharmaceutical Sciences (STIFAR) Semarang City Indonesia
| | - Athika Darumas Putri
- Semarang College of Pharmaceutical Sciences (STIFAR) Semarang City Indonesia
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Pharmacy, Taipei Medical University Taipei Taiwan
| | - Yi-June Huang
- Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
| | - Shih-Min Wei
- Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
| | - Chih-Wei Peng
- International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
| | - Po-Kang Yang
- Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- Department of Biomedical Sciences and Engineering, National Central University Chung-li Taiwan
| |
Collapse
|
14
|
Phan LMT, Hoang TX, Vo TAT, Pham HL, Le HTN, Chinnadayyala SR, Kim JY, Lee SM, Cho WW, Kim YH, Choi SH, Cho S. Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer's Disease. Expert Rev Mol Diagn 2021; 21:175-193. [PMID: 33560154 DOI: 10.1080/14737159.2021.1887732] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
INTRODUCTION Alzheimer's disease (AD), a heterogeneous pathological process representing the most common causes of dementia worldwide, has required early and accurate diagnostic tools. Neuropathological hallmarks of AD involve the aberrant accumulation of Amyloid beta (Aβ) into Amyloid plaques and hyperphosphorylated Tau into neurofibrillary tangles, occurring long before the onset of brain dysfunction.Areas covered:Considering the significance of Aβ and Tau in AD pathogenesis, these proteins have been adopted as core biomarkers of AD, and their quantification has provided precise diagnostic information to develop next-generation AD therapeutic approaches. However, conventional diagnostic methods may not suffice to achieve clinical criteria that are acceptable for proper diagnosis and treatment. The advantages of nanomaterial-based biosensors including facile miniaturization, mass fabrication, ultra-sensitivity, make them useful to be promising tools to measure Aβ and Tau simultaneously for accurate validation of low-abundance yet potentially informative biomarkers of AD.. EXPERT OPINION The study has identified the potential application of advanced biosensors as standardized clinical diagnostic tools for AD, evolving the way for new and efficient AD control with minimum economic and social burden. After clinical trial, nanobiosensors for measuring Aβ and Tau simultaneously possess innovative diagnosis of AD to provide significant contributions to primary Alzheimer's care intervention.
Collapse
Affiliation(s)
- Le Minh Tu Phan
- Department of Electronic Engineering, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea.,School of Medicine and Pharmacy, The University of Danang, Danang, Vietnam
| | - Thi Xoan Hoang
- Department of Life Science, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea
| | - Thuy Anh Thu Vo
- Department of Life Science, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea
| | - Hoang Lan Pham
- Department of Life Science, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea
| | - Hien T Ngoc Le
- Department of Electronic Engineering, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea
| | | | - Jae Young Kim
- Department of Life Science, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea
| | | | - Won Woo Cho
- Cantis Inc., Ansan-si, Gyeonggi-do, Republic of Korea
| | - Young Hyo Kim
- Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Inha University, Incheon, Republic of Korea
| | - Seong Hye Choi
- Department of Neurology, School of Medicine, Inha University, Incheon, Republic of Korea
| | - Sungbo Cho
- Department of Electronic Engineering, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea.,Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea
| |
Collapse
|
15
|
Tapeinos C. Graphene‐Based Nanotechnology in Neurodegenerative Disorders. ADVANCED NANOBIOMED RESEARCH 2021. [DOI: 10.1002/anbr.202000059] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Affiliation(s)
- Christos Tapeinos
- Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Helsinki FI-00014 Finland
| |
Collapse
|
16
|
Roberts A, Chauhan N, Islam S, Mahari S, Ghawri B, Gandham RK, Majumdar SS, Ghosh A, Gandhi S. Graphene functionalized field-effect transistors for ultrasensitive detection of Japanese encephalitis and Avian influenza virus. Sci Rep 2020; 10:14546. [PMID: 32884083 PMCID: PMC7471952 DOI: 10.1038/s41598-020-71591-w] [Citation(s) in RCA: 39] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Accepted: 06/18/2020] [Indexed: 01/21/2023] Open
Abstract
Graphene, a two-dimensional nanomaterial, has gained immense interest in biosensing applications due to its large surface-to-volume ratio, and excellent electrical properties. Herein, a compact and user-friendly graphene field effect transistor (GraFET) based ultrasensitive biosensor has been developed for detecting Japanese Encephalitis Virus (JEV) and Avian Influenza Virus (AIV). The novel sensing platform comprised of carboxy functionalized graphene on Si/SiO2 substrate for covalent immobilization of monoclonal antibodies of JEV and AIV. The bioconjugation and fabrication process of GraFET was characterized by various biophysical techniques such as Ultraviolet-Visible (UV-Vis), Raman, Fourier-Transform Infrared (FT-IR) spectroscopy, optical microscopy, Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM). The change in the resistance due to antigen-antibody interaction was monitored in real time to evaluate the electrical response of the sensors. The sensors were tested in the range of 1 fM to 1 μM for both JEV and AIV antigens, and showed a limit of detection (LOD) upto 1 fM and 10 fM for JEV and AIV respectively under optimised conditions. Along with ease of fabrication, the GraFET devices were highly sensitive, specific, reproducible, and capable of detecting ultralow levels of JEV and AIV antigen. Moreover, these devices can be easily integrated into miniaturized FET-based real-time sensors for the rapid, cost-effective, and early Point of Care (PoC) diagnosis of JEV and AIV.
Collapse
Affiliation(s)
- Akanksha Roberts
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, Telangana, 500032, India
| | - Neha Chauhan
- Department of Physics, Indian Institute of Science (IISc), Bangalore, 560012, India
| | - Saurav Islam
- Department of Physics, Indian Institute of Science (IISc), Bangalore, 560012, India
| | - Subhasis Mahari
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, Telangana, 500032, India
| | - Bhaskar Ghawri
- Department of Physics, Indian Institute of Science (IISc), Bangalore, 560012, India
| | - Ravi Kumar Gandham
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, Telangana, 500032, India
| | - S S Majumdar
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, Telangana, 500032, India
| | - Arindam Ghosh
- Department of Physics, Indian Institute of Science (IISc), Bangalore, 560012, India
- Center for Nanoscience and Engineering, Indian Institute of Science (IISc), Bangalore, 560012, India
| | - Sonu Gandhi
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, Telangana, 500032, India.
| |
Collapse
|
17
|
Ameri M, Shabaninejad Z, Movahedpour A, Sahebkar A, Mohammadi S, Hosseindoost S, Ebrahimi MS, Savardashtaki A, Karimipour M, Mirzaei H. Biosensors for detection of Tau protein as an Alzheimer's disease marker. Int J Biol Macromol 2020; 162:1100-1108. [PMID: 32603732 DOI: 10.1016/j.ijbiomac.2020.06.239] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2020] [Revised: 06/13/2020] [Accepted: 06/25/2020] [Indexed: 12/16/2022]
Abstract
Known as a main neural MAP (microtubule associated protein), tau protein contributes to stabilizing microtubules involved in cellular transmission. Tau dysfunction is mainly associated with neurodegenerative diseases, particularly Alzheimer's disease (AD). In these patients, all the six tau isoforms, which are in hyperphosphorylated form, are first aggregated and then polymerized into neurofibrillary tangles inside the brain. Tau protein detected in cerebrospinal fluid (CSF) is significantly correlated with AD and is well recognized as a hallmark of the disease. Served for detection of analytes of interest, biosensor device comprises a physical transducer and a keen biological recognition component. Qualitative and quantitative evaluations may be performed through analyzation of the data, which is gathered by measurable signals converted from biological reaction. Antibodies, receptors, microorganisms, nucleic acids, enzymes, cells and tissues, as well as some biomimetic structures, normally constitute the biosensor biological recognition part. Production of nanobiosensor, which was made possible through several accomplishments in nano- and fabrication technology, opens up new biotechnological horizons in diagnosis of multiple diseases. In recent years, many researches have been focused on developing novel and effective tau protein biosensors for rapid and accurate detection of AD. In this review, tau protein function and correlation with AD as well as the eminent research on developing nanobiosensor based on optical, electrochemical and piezoelectric approaches will be highlighted.
Collapse
Affiliation(s)
- Mehrdad Ameri
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences Shiraz, Iran; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Zahra Shabaninejad
- Department of Nanobiotechnology, School of Basic Science, Tarbiat Modares University, Tehran, Iran; Pharmaceutical Science Research Center, Shiraz University of Medical Science, Shiraz, Iran
| | - Ahmad Movahedpour
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences Shiraz, Iran; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Amirhossein Sahebkar
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Soheila Mohammadi
- Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Saereh Hosseindoost
- Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Amir Savardashtaki
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences Shiraz, Iran; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
| | - Mohammad Karimipour
- Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
| | - Hamed Mirzaei
- Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
| |
Collapse
|
18
|
P K S, Bathula C, K N C, Das M. Usage of Graphene Oxide in Fluorescence Quenching-Linked Immunosorbent Assay for the Detection of Cry2Ab Protein Present in Transgenic Plants. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2020; 68:3656-3662. [PMID: 32073854 DOI: 10.1021/acs.jafc.9b06650] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Graphene oxide-based sensor technologies in various detection platforms have been adopted in multiple dimensions. Most of the applications in combination with other materials such as gold, silver, enzymes, and so forth are read as electrical, electrochemical, impedance, and fluorescence signals. We report the development of a novel and simple fluorescence quenching-based immunoassay platform that provides quantitative binding sites for the Cry2Ab protein content present in the transgenic cotton (Gossypium hirsutum) plant. In this assay, the graphene oxide-conjugated anti-Cry2Ab antibody serves as the binding site for the analyte Cry2Ab protein, which forms a complex with a second anti-Cry2Ab fluorescein isothiocyanate (FITC)-conjugated antibody. This complex acts as the reaction center of this platform where the graphene oxide quenches the fluorescence signal of the FITC molecule. This microtiter plate-based method currently works at a sensitivity of 0.78 ng /ml, which can further be improved.
Collapse
Affiliation(s)
- Smitha P K
- Department of Biotechnology, Research and Development Centre, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India
- Beyond Antibody, S-005 Krishna Greens, Krishna Temple Road, Dodda Bommasandra, Bangalore 560 097, Karnataka, India
| | - Christopher Bathula
- Tumor Immunology Program, DSRG1, MSCTR, MSMF, 8th floor, Mazumdar Shaw Medical Centre, Narayana Health City, Bommasandra, Bangalore 560 099, Karnataka, India
| | - Chandrashekara K N
- Division of Plant Physiology and Biotechnology, UPASI Tea Research Foundation, Tea Research Institute, Nirar Dam, Valparai, Coimbatore 642 127, Tamil Nadu, India
| | - Manjula Das
- Tumor Immunology Program, DSRG1, MSCTR, MSMF, 8th floor, Mazumdar Shaw Medical Centre, Narayana Health City, Bommasandra, Bangalore 560 099, Karnataka, India
| |
Collapse
|
19
|
Shahdeo D, Roberts A, Abbineni N, Gandhi S. Graphene based sensors. ANALYTICAL APPLICATIONS OF GRAPHENE FOR COMPREHENSIVE ANALYTICAL CHEMISTRY 2020. [PMCID: PMC7518956 DOI: 10.1016/bs.coac.2020.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
The two dimensional, honeycomb structured, single carbon layered graphene has extensively been used in the field of sensor detection due to its unique physicochemical properties. These properties such as excellent electrical conductivity, high electron mobility, tunable optical properties, room temperature quantum Hall effect, large surface to volume ratio, high mechanical strength, and ease of functionalization, make it an ideal nanomaterial for sensor development. This has enabled the fabrication of a large variety of highly sensitive sensors which include colorimetric, electrochemical, potentiometric, fluorescence, etc. based sensors. These sensors in conjugation with graphene or its derivatives such as graphene quantum dots, graphene oxide, reduced graphene oxide, etc. show highly desirable properties such as high sensitivity (detecting minute amounts of target analyte), specificity (no cross reactivity while detecting the target analyte), rapid results, low cost, extended storage shelf life and robustness (stability), and easy-to-use capabilities (user-friendly). This book chapter gives a detailed overview of all the advances made in the development and fabrication of novel graphene based sensors and their application in point of care (PoC) detection of various diseases as well as health monitoring devices. The different sensors, their methods of fabrication, their sensitivity and the analytes and biomolecules used have been discussed in detail and compared.
Collapse
|
20
|
Chen L, Lin J, Yi J, Weng Q, Zhou Y, Han Z, Li C, Chen J, Zhang Q. A tyrosinase-induced fluorescence immunoassay for detection of tau protein using dopamine-functionalized CuInS2/ZnS quantum dots. Anal Bioanal Chem 2019; 411:5277-5285. [DOI: 10.1007/s00216-019-01909-9] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2019] [Revised: 04/24/2019] [Accepted: 05/09/2019] [Indexed: 10/26/2022]
|
21
|
Li Y, Lim E, Fields T, Wu H, Xu Y, Wang YA, Mao H. Improving Sensitivity and Specificity of Amyloid-β Peptides and Tau Protein Detection with Antibiofouling Magnetic Nanoparticles for Liquid Biopsy of Alzheimer’s Disease. ACS Biomater Sci Eng 2019; 5:3595-3605. [DOI: 10.1021/acsbiomaterials.9b00086] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Yuancheng Li
- Department of Radiology and Imaging Sciences, Emory University, 1841 Clifton Road NE, Atlanta, Georgia 30329, United States
| | - Esther Lim
- Division of Research, Philadelphia College of Osteopathic Medicine−Georgia Campus, 625 Old Peachtree Road NW, Suwanee, Georgia 30039, United States
| | - Travis Fields
- Division of Research, Philadelphia College of Osteopathic Medicine−Georgia Campus, 625 Old Peachtree Road NW, Suwanee, Georgia 30039, United States
| | - Hui Wu
- Department of Radiology and Imaging Sciences, Emory University, 1841 Clifton Road NE, Atlanta, Georgia 30329, United States
| | - Yaolin Xu
- Department of Radiology and Imaging Sciences, Emory University, 1841 Clifton Road NE, Atlanta, Georgia 30329, United States
| | - Y. Andrew Wang
- Ocean Nanotech, LLC, 7964 Arjons Drive, San Diego, California 92126, United States of America
| | - Hui Mao
- Department of Radiology and Imaging Sciences, Emory University, 1841 Clifton Road NE, Atlanta, Georgia 30329, United States
| |
Collapse
|
22
|
Kim HS, Lee SH, Choi I. On-chip plasmonic immunoassay based on targeted assembly of gold nanoplasmonic particles. Analyst 2019; 144:2820-2826. [DOI: 10.1039/c8an02489h] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
An on-chip, non-enzymatic immunoassay was developed via the targeted assemblies of gold nanoparticles with target proteins in degassing-driven microfluidic devices and simply quantified at the single particle level.
Collapse
Affiliation(s)
- Hyo Sil Kim
- Department of Life Science
- University of Seoul
- Seoul
- South Korea
| | - Sang Hun Lee
- Department of Bioengineering
- University of California at Berkeley
- Berkeley
- USA
| | - Inhee Choi
- Department of Life Science
- University of Seoul
- Seoul
- South Korea
| |
Collapse
|